UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Wortmannin-mediated inhibition of phosphatidylinositol 3-kinase activity triggers apoptosis in normal and neoplastic B lymphocytes which are in cell cycle

International immunology, 1996-04, Vol.8 (4), p.585-594

1996

Volltextzugriff (PDF)

Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP

FEBS letters, 1996-05, Vol.386 (2), p.115-122

1996

Volltextzugriff (PDF)

Vanadate-Induced Inhibition of BCR-Triggered Apoptosis is Coupled with Tyrosine Phosphorylation and Induction of G2M Growth Arrest in Ramos-BL B Cells

Immunological investigations, 2007-01, Vol.36 (3), p.293-306

2007

Volltextzugriff (PDF)

Regulation of tyrosine phosphorylation during the CD40-mediated rescue of Ramos-BL B cells from BCR-triggered apoptosis

International journal of molecular medicine, 2005-11, Vol.16 (5), p.937

2005

Volltextzugriff (PDF)

Clinical trials explained: a guide to clinical trials in the NHS for healthcare professionals

1st ed., 2008

Volltextzugriff (PDF)

LY294002-Mediated Inhibition of Phosphatidylinositol 3-Kinase Activity Triggers Growth Inhibition and Apoptosis in CD40-Triggered Ramos–Burkitt Lymphoma B Cells

Cellular immunology, 1998-08, Vol.187 (2), p.77-87

1998

Volltextzugriff (PDF)

Inhibition of ICE-family cysteine proteases rescues murine lymphocytes from lipoxygenase inhibitor-induced apoptosis

FEBS letters, 1996-11, Vol.396 (2), p.266-270

1996

Volltextzugriff (PDF)

Protein tyrosine phosphorylation is mandatory for CD40‐mediated rescue of germinal center B cells from apoptosis

European journal of immunology, 1993-10, Vol.23 (10), p.2578-2584

1993

Volltextzugriff (PDF)

Ligation of CD40 Potentiates Fas-Mediated Activation of the Cysteine Protease CPP32, Cleavage of Its Death Substrate PARP, and Apoptosis in Ramos–Burkitt Lymphoma B Cells

Cellular immunology, 1997-11, Vol.181 (2), p.139-152

1997

Volltextzugriff (PDF)

A Study of Protein Kinase C Isozyme Distribution in Relation to Bcl-2 Expression during Apoptosis of Epithelial Cells in Vivo

Experimental cell research, 1993-07, Vol.207 (1), p.68-73

1993

Volltextzugriff (PDF)

Differential Regulatory Effects of cAMP-Elevating Agents on Human Normal and Neoplastic B Cell Functional Response Following Ligation of Surface Immunoglobulin and CD40

Cellular immunology, 1995-11, Vol.166 (1), p.93-102

1995

Volltextzugriff (PDF)

Second‐messenger pathways involved in the regulation of survival in germinal‐centre B cells and in burkitt lymphoma lines

International journal of cancer, 1992-12, Vol.52 (6), p.959-966

1992

Volltextzugriff (PDF)

Distribution of cAMP in secondary follicles and its expression in B cell apoptosis and CD40-mediated survival

International immunology, 1993-09, Vol.5 (9), p.1085-1091

1993

Volltextzugriff (PDF)

Protein Tyrosine Kinases Couple the Surface Immunoglobulin of Germinal Center B Cells to Phosphatidylinositol-Dependent and -Independent Pathways of Rescue from Apoptosis

Cellular immunology, 1994-04, Vol.155 (1), p.62-76

1994

Volltextzugriff (PDF)

CD40-Triggered Protein Tyrosine Phosphorylation on Vav and on Phosphatidylinositol 3-Kinase Correlates with Survival of the Ramos–Burkitt Lymphoma B Cell Line

Cellular immunology, 1997-05, Vol.177 (2), p.119-128

1997

Volltextzugriff (PDF)

Stimulation of human B lymphocytes by phorbol esters reported to be selective in the protein kinase C isoforms they activate

Molecular immunology, 1994-06, Vol.31 (9), p.671-674

1994

Volltextzugriff (PDF)

Lymphocytes from HIV-infected individuals show aberrant inositol polyphosphate metabolism which reverses after zidovudine therapy

AIDS (London), 1991-04, Vol.5 (4), p.413-417

1991

Volltextzugriff (PDF)

Overview and Purpose of This Guide to Clinical Trials in the NHS

Clinical Trials Explained, 2006, p.1-3

2006

Volltextzugriff (PDF)

Understanding Clinical Trial Design and Results

Clinical Trials Explained, 2006, p.29-37

2006

Volltextzugriff (PDF)

Clinical Trial Approval, Regulation and Funding

Clinical Trials Explained, 2006, p.19-28

2006

Volltextzugriff (PDF)

Clinical Trials Explained: A Guide to Clinical Trials in the NHS for Healthcare Professionals

Clinical Trials Explained, 2006

2006

Volltextzugriff (PDF)

Appendix A Finding Out About Clinical Trials that are Currently or Soon to be Recruiting

Clinical Trials Explained, 2006, p.49-49

2006

Volltextzugriff (PDF)

Appendix B: ECRI Evidence Report: Patients' Reasons for Participation in Clinical Trials and Effect of Trial Participation on Patient Outcomes

Clinical Trials Explained, 2006, p.50-82

2006

Volltextzugriff (PDF)

Intro

Clinical Trials Explained, 2006

2006

Volltextzugriff (PDF)

Clinical Trials Explained

Clinical Trials Explained, 2006, p.4-18

2006

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Wortmannin-mediated inhibition of phosphatidylinositol 3-kinase activity triggers apoptosis in normal and neoplastic B lymphocytes which are in cell cycle

Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP

Vanadate-Induced Inhibition of BCR-Triggered Apoptosis is Coupled with Tyrosine Phosphorylation and Induction of G2M Growth Arrest in Ramos-BL B Cells

Regulation of tyrosine phosphorylation during the CD40-mediated rescue of Ramos-BL B cells from BCR-triggered apoptosis

Clinical trials explained: a guide to clinical trials in the NHS for healthcare professionals

LY294002-Mediated Inhibition of Phosphatidylinositol 3-Kinase Activity Triggers Growth Inhibition and Apoptosis in CD40-Triggered Ramos–Burkitt Lymphoma B Cells

Inhibition of ICE-family cysteine proteases rescues murine lymphocytes from lipoxygenase inhibitor-induced apoptosis

Protein tyrosine phosphorylation is mandatory for CD40‐mediated rescue of germinal center B cells from apoptosis

Ligation of CD40 Potentiates Fas-Mediated Activation of the Cysteine Protease CPP32, Cleavage of Its Death Substrate PARP, and Apoptosis in Ramos–Burkitt Lymphoma B Cells

A Study of Protein Kinase C Isozyme Distribution in Relation to Bcl-2 Expression during Apoptosis of Epithelial Cells in Vivo

Differential Regulatory Effects of cAMP-Elevating Agents on Human Normal and Neoplastic B Cell Functional Response Following Ligation of Surface Immunoglobulin and CD40

Second‐messenger pathways involved in the regulation of survival in germinal‐centre B cells and in burkitt lymphoma lines

Distribution of cAMP in secondary follicles and its expression in B cell apoptosis and CD40-mediated survival

Protein Tyrosine Kinases Couple the Surface Immunoglobulin of Germinal Center B Cells to Phosphatidylinositol-Dependent and -Independent Pathways of Rescue from Apoptosis

CD40-Triggered Protein Tyrosine Phosphorylation on Vav and on Phosphatidylinositol 3-Kinase Correlates with Survival of the Ramos–Burkitt Lymphoma B Cell Line

Stimulation of human B lymphocytes by phorbol esters reported to be selective in the protein kinase C isoforms they activate

Lymphocytes from HIV-infected individuals show aberrant inositol polyphosphate metabolism which reverses after zidovudine therapy

Overview and Purpose of This Guide to Clinical Trials in the NHS

Understanding Clinical Trial Design and Results

Clinical Trial Approval, Regulation and Funding

Clinical Trials Explained: A Guide to Clinical Trials in the NHS for Healthcare Professionals

Appendix A Finding Out About Clinical Trials that are Currently or Soon to be Recruiting

Appendix B: ECRI Evidence Report: Patients' Reasons for Participation in Clinical Trials and Effect of Trial Participation on Patient Outcomes

Intro

Clinical Trials Explained

Suchergebnisse filtern